D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
ZVRA holding history
Zevra Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ZVRA overviewAll 13F holders of ZVRAFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,306,949
- Value
- $18.7M
- % of portfolio
- <0.1%
- Quarters held
- 9
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,306,949 | $18.7M | <0.1% | +460,492+54.4% | Added | Holders |
| Q1 2026 | 846,457 | $7.89M | <0.1% | −17,289−2.0% | Reduced | Holders |
| Q4 2025 | 863,746 | $7.74M | <0.1% | +137,916+19.0% | Added | Holders |
| Q3 2025 | 725,830 | $6.90M | <0.1% | +536,517+283.4% | Added | Holders |
| Q2 2025 | 189,313 | $1.67M | <0.1% | +161,943+591.7% | Added | Holders |
| Q1 2025 | 27,370 | $205.0K | <0.1% | +2,295+9.2% | Added | Holders |
| Q4 2024 | 25,075 | $209.1K | <0.1% | +25,075 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,453−100.0% | Sold out | Holders |
| Q1 2022 | 10,453 | $53.0K | <0.1% | −13,356−56.1% | Reduced | Holders |
| Q4 2021 | 23,809 | $207.0K | <0.1% | +23,809 | New | Holders |